MCVE.F Stock Overview
Provides healthcare and diagnostic services in Poland, Sweden, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Medicover AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 15.05 |
| 52 Week High | SEK 18.75 |
| 52 Week Low | SEK 12.25 |
| Beta | 1.46 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | 33.66% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 80.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| MCVE.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -5.0% | -3.5% |
| 1Y | 33.7% | -11.4% | 22.1% |
Return vs Industry: MCVE.F exceeded the US Healthcare industry which returned -8.9% over the past year.
Return vs Market: MCVE.F exceeded the US Market which returned 24% over the past year.
Price Volatility
| MCVE.F volatility | |
|---|---|
| MCVE.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MCVE.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine MCVE.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 45,000 | Fredrik Rågmark | www.medicover.com |
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company’s Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology.
Medicover AB (publ) Fundamentals Summary
| MCVE.F fundamental statistics | |
|---|---|
| Market cap | US$2.66b |
| Earnings (TTM) | US$20.49m |
| Revenue (TTM) | US$2.08b |
129.9x
P/E Ratio1.3x
P/S RatioIs MCVE.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCVE.F income statement (TTM) | |
|---|---|
| Revenue | €2.00b |
| Cost of Revenue | €1.58b |
| Gross Profit | €413.60m |
| Other Expenses | €393.90m |
| Earnings | €19.70m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 20.70% |
| Net Profit Margin | 0.99% |
| Debt/Equity Ratio | 121.9% |
How did MCVE.F perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield91%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 11:31 |
| End of Day Share Price | 2024/12/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medicover AB (publ) is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Lars Hevreng | Danske Bank |
| James Alexander Vane-Tempest | Jefferies LLC |